Ginger (Zingiber officinale) and turmeric supplementation effects in osteoporosis

Early Phase 1

• Conditions: Postmenopausal osteoporosis.; Postmenopausal osteoporosis; M81.0

• Registration Number: IRCT20161022030424N3
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 120

Inclusion Criteria

Natural menopause
Age 45 and above
Menstrual cessation for 12 consecutive months
low bone density (Score T minus 2.5 and lower)
No history of fracture

Exclusion Criteria

Use Contraceptive Pills or Corticostroids During Study
Kidney disease or failure
Metastatic bone disease
Taking medications that affect bone metabolism other than taking calcium-D supplements or Alendronate that are given to all subjects with the same dose.
Malignancy
coagulation disorders

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life. Timepoint: Evaluating the quality of life at the beginning of the study (before the intervention) and 4 months after the intervention began. Method of measurement: The Menopause Specific Quality of Life Questionnaire.;Body composition. Timepoint: Evaluating the Body composition at the beginning of the study (before the intervention) and 4 months after the intervention began. Method of measurement: Body composition analyzer.;Bone mineral density. Timepoint: Measuring serum Bone mineral density at the beginning of the study (before the intervention) and 4 months after the intervention began. Method of measurement: Dual X-ray absorptiometry (DXA).